Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Due Diligence Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Exchange
Industry
DD Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
CPRX
CATALYST PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.78B$23.270.04%$226.52M18.62x0.17
EXEL
EXELIXIS INC
NASDAQ
Biotechnology
$9.80B$35.001.48%$737.90M19.44x0.31
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
NASDAQ
Biotechnology
$2.22B$38.98-0.24%$228.32M18.13x0.56
CORT
CORCEPT THERAPEUTICS INC
NASDAQ
Biotechnology
$7.62B$72.72-1.21%$143.51M53.47x0.23
HALO
HALOZYME THERAPEUTICS INC
NASDAQ
Biotechnology
$7.42B$58.29-0.55%$580.46M18.99x3.68
GMAB
GENMAB A
NASDAQ
Biotechnology
$14.10B$21.301.82%$1.61B12.48x0.25
ADMA
ADMA BIOLOGICS INC
NASDAQ
Biotechnology
$3.76B$15.90-1.12%$98.83M54.83x0.68
ACAD
ACADIA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$3.33B$20.041.37%$149.00M25.69x0.69
AGIO
AGIOS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.90B$33.22-0.24%$735.15M2.80x0.08
BMRN
BIOMARIN PHARMACEUTICAL INC
NASDAQ
Biotechnology
$12.36B$64.850.67%$507.32M38.15x0.27
SRPT
SAREPTA THERAPEUTICS INC
NASDAQ
Biotechnology
$10.31B$107.95-1.38%$184.19M69.20x1.95
KRYS
KRYSTAL BIOTECH INC
NASDAQ
Biotechnology
$4.41B$153.24-1.61%$65.00M83.28x0.11
UTHR
UNITED THERAPEUTICS CORP
NASDAQ
Biotechnology
$16.54B$370.580.04%$1.55B15.24x0.17
LGND
LIGAND PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.27B$120.005.33%$97.81M45.45x0.14
RPRX
ROYALTY PHARMA PLC
NASDAQ
Biotechnology
$18.65B$32.36-0.31%$1.08B16.85x0.76
VCEL
VERICEL CORP
NASDAQ
Biotechnology
$2.82B$57.090.49%$17.36M815.57x0.52
REGN
REGENERON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$73.64B$673.60-0.10%$5.32B16.47x0.29
GNFT
GENFIT SA
NASDAQ
Biotechnology
$206.26M$4.13-1.60%$31.97M8.35x1.00
DNTH
DIANTHUS THERAPEUTICS INC
NASDAQ
Biotechnology
$724.83M$24.491.49%-$66.66M3.42x0.05
NVO
NOVO NORDISK A S
NYSE
Biotechnology
$347.69B$77.87-1.22%$20.43B24.60x2.25
PBYI
PUMA BIOTECHNOLOGY INC
NASDAQ
Biotechnology
$140.39M$2.86-1.72%$49.42M5.96x2.11
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
NASDAQ
Biotechnology
$1.43B$19.740.46%-$11.78M-151.85x0.27
CDXC
CHROMADEX CORP
NASDAQ
Biotechnology
$448.37M$5.875.20%$3.36M587.00x0.65
TRDA
ENTRADA THERAPEUTICS INC
NASDAQ
Biotechnology
$502.92M$13.446.41%$79.94M8.05x0.31
CVAC
CUREVAC NV
NASDAQ
Biotechnology
$818.83M$3.650.00%$169.95M7.01x0.18
INCY
INCYTE CORP
NASDAQ
Biotechnology
$13.63B$70.420.59%$408.16M440.13x0.58
MDXG
MIMEDX GROUP INC
NASDAQ
Biotechnology
$1.23B$8.401.45%$75.89M13.33x0.35
KPRX
KIORA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$10.86M$3.620.56%$5.62M0.98x0.28
DTIL
PRECISION BIOSCIENCES INC
NASDAQ
Biotechnology
$40.43M$5.274.15%$15.97M27.74x1.36
PTGX
PROTAGONIST THERAPEUTICS INC
NASDAQ
Biotechnology
$2.30B$38.67-0.03%$176.27M13.38x0.14
TGTX
TG THERAPEUTICS INC
NASDAQ
Biotechnology
$4.78B$30.71-0.07%$5.74M-341.22x2.05
VYNE
VYNE THERAPEUTICS INC
NASDAQ
Biotechnology
$36.44M$2.47-0.60%-$34.00M0.73x0.20
FULC
FULCRUM THERAPEUTICS INC
NASDAQ
Biotechnology
$199.03M$3.69-0.54%-$16.18M-12.72x0.08
JAZZ
JAZZ PHARMACEUTICALS PLC
NASDAQ
Biotechnology
$8.10B$133.96-2.09%$1.30B17.98x1.94
PMCB
PHARMACYTE BIOTECH INC
NASDAQ
Biotechnology
$11.36M$1.63-0.61%$22.68M3.08x0.27
APRE
APREA THERAPEUTICS INC
NASDAQ
Biotechnology
$19.49M$3.591.59%-$14.81M-1.28x0.23
AXSM
AXSOME THERAPEUTICS INC
NASDAQ
Biotechnology
$6.36B$131.15-0.40%-$297.22M-19.93x5.04
RIGL
RIGEL PHARMACEUTICALS INC
NASDAQ
Biotechnology
$379.96M$21.573.40%$13.67M86.28x-10.53
IRD
OPUS GENETICS INC
NASDAQ
Biotechnology
$35.67M$1.13-1.74%-$27.19M-1.04x0.18
VRDN
VIRIDIAN THERAPEUTICS INC
NASDAQ
Biotechnology
$1.30B$16.40-3.64%-$253.24M-3.81x0.09
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$488.93M$18.059.99%-$65.72M-7.71x0.42
ARGX
ARGENX SE
NASDAQ
Biotechnology
$38.23B$639.41-1.83%-$124.99M-168.09x0.13
CAPR
CAPRICOR THERAPEUTICS INC
NASDAQ
Biotechnology
$725.25M$15.952.57%-$32.76M-15.64x0.36
VTGN
VISTAGEN THERAPEUTICS INC
NASDAQ
Biotechnology
$85.72M$2.974.21%-$46.68M-2.01x0.14
VYGR
VOYAGER THERAPEUTICS INC
NASDAQ
Biotechnology
$231.07M$4.23-3.42%$20.12M6.13x0.29
SPRO
SPERO THERAPEUTICS INC
NASDAQ
Biotechnology
$44.43M$0.82-0.24%$3.65M10.19x1.06
BRTX
BIORESTORATIVE THERAPIES INC
NASDAQ
Biotechnology
$15.85M$2.29-6.91%-$5.70M-3.95x0.46
IFRX
INFLARX NV
NASDAQ
Biotechnology
$117.77M$2.00-25.93%-$60.57M-1.88x0.22
ALT
ALTIMMUNE INC
NASDAQ
Biotechnology
$453.06M$6.372.25%-$101.42M-4.06x0.11
LEGN
LEGEND BIOTECH CORP
NASDAQ
Biotechnology
$6.68B$36.420.08%-$301.26M-18.97x0.56
BCYC
BICYCLE THERAPEUTICS PLC
NASDAQ
Biotechnology
$866.53M$12.550.48%-$160.02M-3.85x0.20
OCUL
OCULAR THERAPEUTIX INC
NASDAQ
Biotechnology
$1.14B$7.28-2.67%-$155.92M-5.52x0.39
PRTA
PROTHENA CORP PUBLIC LTD CO
NASDAQ
Biotechnology
$762.47M$14.172.02%-$134.84M-5.76x0.11
CMPX
COMPASS THERAPEUTICS INC
NASDAQ
Biotechnology
$465.05M$3.38-2.03%-$45.90M-9.39x0.08
CLDX
CELLDEX THERAPEUTICS INC
NASDAQ
Biotechnology
$1.51B$22.70-1.56%-$150.96M-8.80x0.05
CMRX
CHIMERIX INC
NASDAQ
Biotechnology
$393.92M$4.38-3.95%-$83.61M-4.61x0.17
JANX
JANUX THERAPEUTICS INC
NASDAQ
Biotechnology
$1.91B$36.37-2.15%-$58.46M-31.35x0.06
CGON
CG ONCOLOGY INC
NASDAQ
Biotechnology
$1.93B$28.520.07%-$75.16M-5.38x0.03
QSI
QUANTUM-SI INC
NASDAQ
Biotechnology
$278.29M$1.95-3.94%-$83.47M-3.05x0.12
CNTB
CONNECT BIOPHARMA HOLDINGS LTD
NASDAQ
Biotechnology
$50.84M$0.92-4.95%N/A-2.27x0.09
ORMP
ORAMED PHARMACEUTICALS INC
NASDAQ
Biotechnology
$96.75M$2.40-2.04%-$5.30M21.82x0.06
ZVRA
ZEVRA THERAPEUTICS INC
NASDAQ
Biotechnology
$430.74M$8.071.00%-$73.48M-4.10x1.75
CRGX
CARGO THERAPEUTICS INC
NASDAQ
Biotechnology
$170.30M$3.700.27%-$147.33M0.05x0.13
AUPH
AURINIA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.12B$7.79-2.26%$4.39M-55.64x0.42
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
NASDAQ
Biotechnology
$41.24M$3.60-4.48%-$17.05M-2.34x0.33
TSHA
TAYSHA GENE THERAPIES INC
NASDAQ
Biotechnology
$334.06M$1.630.62%-$19.48M2.59x1.03
KRON
KRONOS BIO INC
NASDAQ
Biotechnology
$61.55M$1.020.00%-$81.03M-0.71x0.35
ARDX
ARDELYX INC
NASDAQ
Biotechnology
$1.37B$5.792.30%-$55.42M-18.68x1.32
URGN
UROGEN PHARMA LTD
NASDAQ
Biotechnology
$454.49M$10.772.18%-$97.82M-3.49x10.83
FOLD
AMICUS THERAPEUTICS INC
NASDAQ
Biotechnology
$2.92B$9.771.35%-$9.20M-28.74x3.40
KROS
KEROS THERAPEUTICS INC
NASDAQ
Biotechnology
$418.04M$10.321.67%-$178.84M-1.98x0.09
RYTM
RHYTHM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$3.48B$56.69-1.51%-$237.53M-13.09x18.80
TARS
TARSUS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.92B$50.22-3.85%-$126.08M-13.32x0.59
AUTL
AUTOLUS THERAPEUTICS PLC
NASDAQ
Biotechnology
$542.89M$2.045.15%-$172.59M-1.67x0.74
IOVA
IOVANCE BIOTHERAPEUTICS INC
NASDAQ
Biotechnology
$1.70B$5.574.31%-$374.51M-3.74x0.28
STTK
SHATTUCK LABS INC
NASDAQ
Biotechnology
$63.49M$1.336.40%-$70.14M-0.87x0.16
MNKD
MANNKIND CORP
NASDAQ
Biotechnology
$1.49B$5.42-2.34%$68.79M67.75x-3.21
VALN
VALNEVA SE
NASDAQ
Biotechnology
$463.27M$6.67-14.38%N/A-61.76x1.38
FENC
FENNEC PHARMACEUTICALS INC
NASDAQ
Biotechnology
$183.25M$6.68-0.89%$4.57M-167.00x-12.40
TECH
BIO-TECHNE CORP
NASDAQ
Biotechnology
$10.42B$65.94-1.24%$312.12M65.94x0.29
STOK
STOKE THERAPEUTICS INC
NASDAQ
Biotechnology
$565.69M$10.680.47%-$113.16M-5.09x0.26
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
NASDAQ
Biotechnology
$8.29M$4.743.27%-$5.20M-1.25x0.05
CRVO
CERVOMED INC
NASDAQ
Biotechnology
$19.23M$2.336.39%-$11.95M-1.07x0.07
SNDX
SYNDAX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.27B$14.92-1.06%-$295.84M-4.10x0.16
MIRM
MIRUM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.40B$50.04-1.30%-$59.49M-24.06x1.88
VCYT
VERACYTE INC
NASDAQ
Biotechnology
$3.19B$41.113.84%$20.03M-316.23x0.08
SKYE
SKYE BIOSCIENCE INC
NASDAQ
Biotechnology
$95.87M$3.163.27%-$19.85M5.96x0.08
NTLA
INTELLIA THERAPEUTICS INC
NASDAQ
Biotechnology
$1.09B$10.7011.00%-$512.10M-1.97x0.22
ROIV
ROIVANT SCIENCES LTD
NASDAQ
Biotechnology
$7.54B$10.561.05%-$183.53M-55.58x0.05
MDGL
MADRIGAL PHARMACEUTICALS INC
NASDAQ
Biotechnology
$7.35B$337.20-4.13%-$503.11M-13.42x0.38
SXTP
60 DEGREES PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.36M$0.59-5.59%-$8.52M-0.06x0.24
EPIX
ESSA PHARMA INC
NASDAQ
Biotechnology
$76.79M$1.73-0.57%-$31.02M-2.51x0.03
VNDA
VANDA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$257.72M$4.42-5.96%-$10.77M-15.24x0.19
PHAR
PHARMING GROUP NV
NASDAQ
Biotechnology
$624.09M$9.203.99%-$1.37M-31.72x0.89
ARQT
ARCUTIS BIOTHERAPEUTICS INC
NASDAQ
Biotechnology
$1.50B$12.783.82%-$162.89M-7.70x1.79
ALNY
ALNYLAM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$33.20B$256.45-3.19%-$178.85M-117.64x62.20
SPRY
ARS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.17B$12.020.84%-$49.04M-23.57x0.08
NTRB
NUTRIBAND INC
NASDAQ
Biotechnology
$79.08M$7.12-5.94%-$6.49M-10.03x0.12
BPMC
BLUEPRINT MEDICINES CORP
NASDAQ
Biotechnology
$6.00B$93.94-1.31%-$11.50M-87.79x2.95
ABVX
ABIVAX SA
NASDAQ
Biotechnology
$465.70M$7.403.21%-$169.35M-2.05x1.25

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Feb 2025?

According to Due Diligence Score, the 3 best biotechnology stocks to buy right now are:

1. Catalyst Pharmaceuticals (NASDAQ:CPRX)


Catalyst Pharmaceuticals (NASDAQ:CPRX) is the top biotech stock with a Due Diligence Score of 76, which is 53 points higher than the biotech industry average of 23. It passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 72.63% over the past year, overperforming other biotech stocks by 106 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $32.80, an upside of 40.95% from Catalyst Pharmaceuticals's current stock price of $23.27.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Exelixis (NASDAQ:EXEL)


Exelixis (NASDAQ:EXEL) is the second best biotech stock with a Due Diligence Score of 74, which is 51 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 71.65% over the past year, overperforming other biotech stocks by 105 percentage points.

Exelixis has an average 1 year price target of $37.24, an upside of 6.39% from Exelixis's current stock price of $35.00.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 17 analysts covering Exelixis, 41.18% have issued a Strong Buy rating, 17.65% have issued a Buy, 41.18% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the third best biotech stock with a Due Diligence Score of 72, which is 49 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock return 15.02% over the past year, overperforming other biotech stocks by 48 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $55.88, an upside of 43.34% from Harmony Biosciences Holdings's current stock price of $38.98.

Harmony Biosciences Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Harmony Biosciences Holdings, 37.5% have issued a Strong Buy rating, 62.5% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 3 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Novo Nordisk (Ozempic) (NYSE:NVO)


Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 1.85%, which is 1 percentage points higher than the biotech industry average of 0.72%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 0.65%, which is the same as the biotech industry average of 0.72%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.36%, which is the same as the biotech industry average of 0.72%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 32% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.13% in the last day, and down -0.08% over the last week. Recursion Pharmaceuticals was the among the top gainers in the biotechnology industry, gaining 23.88% yesterday.

Recursion Pharmaceuticals shares are trading higher after a 13F filing showed SoftBank Group took a new stake of 14.67 million shares.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Exelixis (NASDAQ:EXEL)


Exelixis (NASDAQ:EXEL) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Exelixis has a valuation score of 86, which is 71 points higher than the biotech industry average of 15. It passed 6 out of 7 valuation due diligence checks.

Exelixis's stock has gained 71.65% in the past year. It has overperformed other stocks in the biotech industry by 105 percentage points.

2. Cargo Therapeutics (NASDAQ:CRGX)


Cargo Therapeutics (NASDAQ:CRGX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Cargo Therapeutics has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Cargo Therapeutics's stock has dropped -82.87% in the past year. It has underperformed other stocks in the biotech industry by -50 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 15.02% in the past year. It has overperformed other stocks in the biotech industry by 48 percentage points.

Are biotech stocks a good buy now?

55.62% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 95.09% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -169.22x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.